Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Patent
1998-03-13
2000-08-08
Ketter, James
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
4353201, 536 241, C12Q 168
Patent
active
061000329
ABSTRACT:
Two human Smad proteins (Smad3 and Smad4) specifically recognize an identical 8 bp palindromic sequence (GTCTAGAC) (SEQ ID NO: 1). Tandem repeats of this palindrome confer striking TGF-.beta. responsiveness to a minimal promoter. This responsiveness is abrogated by targeted deletion of the cellular Smad4 gene. DNA molecules comprising the 8 bp palindromic sequence can be used in assays for drug screening and diagnostically.
REFERENCES:
patent: 5168499 (1992-12-01), Peterson et al.
patent: 5712097 (1998-01-01), Kern et al.
Kinzler et al. "Whole genome PCR: application to the identiification of sequences bound by gene regulatory proteins" Nucleic Acids Research vol. 17, No. 10, 1989, pp. 3645-3853.
Arnold R. Oliphant et al. "Defining the Sequence Specificity of DNA-Binding Proteins by Selecting Binding Sites from Random-Sequence Oligonucleotides: Analysis of Yeast GCN4 Protein" Molecular and Cellular Biology, Jul. 1989, pp. 2944-2949.
Dai Jia Le
Kern Scott Eliot
Kinzler Kenneth W.
Vogelstein Bert
Zawel Leigh
Johns Hopkins University
Ketter James
LandOfFree
Human Smad3 and Smad4 are sequence-specific transcription activa does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human Smad3 and Smad4 are sequence-specific transcription activa, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human Smad3 and Smad4 are sequence-specific transcription activa will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1148808